Circulating Fibrocytes in Non-small Cell Lung Cancer.
NCT01998425 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 60
Last updated 2015-07-31
Summary
The investigators will collect fibrocytes (CD45+Col-1+) in patients with non-small cell lung cancer (NSCLC). The investigators hypothesize that patients with NSCLC experience expansion of immunosuppressive fibrocytes, which are predicted to augment tumor growth by mediating immune escape in NSCLC patients.
Conditions
Sponsors & Collaborators
-
Chang Gung Memorial Hospital
lead OTHER
Eligibility
- Min Age
- 20 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2013-11-30
- Primary Completion
- 2017-02-28
- Completion
- 2017-07-31
Countries
- Taiwan
Study Locations
More Related Trials
-
Study of Tissue Samples From Patients With Non-Small Cell Lung Cancer
NCT01414595 ·Status: COMPLETED
-
Established Lung Cancer Cell Line and Stroma Cell From Surgical Tissue
NCT01058811 ·Status: UNKNOWN
-
Study of Tumor Samples From Patients With Lung Cancer
NCT00900328 ·Status: COMPLETED
-
A Study of the Correlation Between CRF, Survival and Physiological Factors in NSCLC Patients Under Chemotherapy
NCT03130192 ·Status: UNKNOWN
-
Correlation Between EGFR Mutation Using cfDNAs and Circulating Tumor Cells in Patients With NSCLC
NCT02422628 ·Status: UNKNOWN
-
Circulating Immune Markers for Prognostic Evaluation in Postoperative Lung Cancer Patients
NCT07242482 ·Status: NOT_YET_RECRUITING
-
Study of the Correlation of Tumor Tissue Microbiome to the Pathogenesis of Lung Cancer
NCT04260295 ·Status: UNKNOWN
-
A Comprehensive Evaluation of Circulating Tumor DNA and Circulating Tumor Cells as a Predictive Marker in Lung Cancer
NCT04254497 ·Status: COMPLETED
-
Recurrent Predictive Power of Circulating Tumor Cells for Non Small Cell Lung Cancer Patients
NCT03721133 ·Status: ENROLLING_BY_INVITATION
-
Therapeutic and Prognostic Impact of Circulating Tumor Cells in Peripheral Blood in Patients With Non Small-cell Lung Cancer
NCT01052818 ·Status: UNKNOWN
-
Tissue Collection Study for Patients With Non-Small Cell Lung Cancer With Resectable Disease
NCT01450553 ·Status: UNKNOWN
-
Genomic Study in Non-small Cell Lung Cancer Brain Metastasis
NCT04745715 ·Status: COMPLETED
-
Therapeutic ResistAnce and Clonal Evolution Assessed With Liquid Biopsy in ICIs Treated NSCLC Patients
NCT04566432 ·Status: RECRUITING
-
Detection of Early Metastases in Patients With Stage I Non-small Cell Lung Cancer
NCT00003006 ·Status: COMPLETED
-
Studies of Phenotypic and Functional Characteristics of Circulating Neutrophil Subpopulations in Patients With Lung Cancer
NCT06244355 ·Status: RECRUITING
-
Identifying Biomarkers for Lung Cancer Using Tissue Samples From Patients With Lung Cancer and From Healthy Participants
NCT00899028 ·Status: COMPLETED
-
The Utility of Circulating Tumor Cells as Confirmation of Pathologic Diagnosis in Patients With Suspected Early Stage Non-small Cell Lung Cancer
NCT02380196 ·Status: COMPLETED
-
Study of Blood, Tumor and Adjacent Normal Tissue Samples From Chinese Smoking Induced Lung Cancer Patients
NCT02113852 ·Status: COMPLETED
-
Analysis of Deoxyribonucleic Acid and Ribonucleic Acid Next-Generation Sequencing in Non-Small Cell Lung Cancer Patients Without Pathological Complete Response Following Neoadjuvant Immunotherapy
NCT07179445 ·Status: NOT_YET_RECRUITING
-
Correlation of Metabolic Imaging With Immune Markers in NSCLC Candidate to Immunotherapy.
NCT03563482 ·Status: UNKNOWN ·Phase: NA
-
Studying Tumor Tissue Samples From Patients With Early-Stage Non-Small Cell Lung Cancer
NCT01517971 ·Status: COMPLETED
-
A Prospective, Observational Trial on the Diagnostic and Prognostic of LM
NCT02607605 ·Status: UNKNOWN
-
Evaluation of Tumor and Blood Immune Biomarkers in Resected Non-small Cell Lung Cancer
NCT02848872 ·Status: COMPLETED
-
Examination of Trends in Non-Small Cell Lung Cancer Patients' Medical Study Experiences
NCT05778045 ·Status: NOT_YET_RECRUITING
-
A Study of Predictive and Prognostic Markers in Patients With Non-small Cell Lung Cancer
NCT00958555 ·Status: UNKNOWN